Loustau, M. (Maria)

Filtering

20121

Settings

Author search.filters.isAuthorOfPublication.6ca3aaff-2fa6-4dc9-9582-d9b04c390c06

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors
    (Springer, 2012) Caumartin, J. (Julien); Alegre-Martinez, E. (Estibaliz); Sousa, S. (Sylvie); Daouya, M. (Marina); Loustau, M. (Maria); LeMaoult, J. (Joël); Horuzsko, A. (Anatolij); Carosella, E.D. (Edgardo D.); HoWangYin, K.Y. (Kiave-Yune); Wu, J. (Juan)
    The non-classical Human leukocyte antigen G (HLA-G) differs from classical HLA class I molecules by its low genetic diversity, a tissue-restricted expression, the existence of seven isoforms, and immuno-inhibitory functions. Most of the known functions of HLA-G concern the membrane-bound HLA-G1 and soluble HLA-G5 isoforms, which present the typical structure of classical HLA class I molecule: a heavy chain of three globular domains α(1)-α(2)-α(3) non-covalently bound to β-2-microglobulin (B2M) and a peptide. Very little is known of the structural features and functions of other HLA-G isoforms or structural conformations other than B2M-associated HLA-G1 and HLA-G5. In the present work, we studied the capability of all isoforms to form homomultimers, and investigated whether they could bind to, and function through, the known HLA-G receptors LILRB1 and LILRB2. We report that all HLA-G isoforms may form homodimers, demonstrating for the first time the existence of HLA-G4 dimers. We also report that the HLA-G α(1)-α(3) structure, which constitutes the extracellular part of HLA-G2 and HLA-G6, binds the LILRB2 receptor but not LILRB1. This is the first report of a receptor for a truncated HLA-G isoform. Following up on this finding, we show that the α(1)-α(3)-Fc structure coated on agarose beads is tolerogenic and capable of prolonging the survival of skin allografts in B6-mice and in a LILRB2-transgenic mouse model. This study is the first proof of concept that truncated HLA-G isoforms could be used as therapeutic agents.